Celgene Stock Price, News & Analysis

CELG

Company Description

Celgene (CELG) is a publicly traded company.

This page provides a comprehensive overview of CELG stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

711.4M

Shares outstanding

Latest News

View All

No recent news available for CELG.

SEC Filings

View All

April 2, 2026

[4] Bristol Myers (NYSE: BMY) EVP converts 3,307 RSUs and updates holdings

April 2, 2026

[4] Bristol Myers (NYSE: BMY) CFO sells 30,000 shares under 10b5-1 plan

April 2, 2026

[4] Director at Bristol Myers (NYSE: BMY) receives new deferred share units

April 2, 2026

[4] Bristol Myers (NYSE: BMY) grants director new deferred share units

April 2, 2026

[4] Bristol Myers (NYSE: BMY) director adds deferred share units award

Celgene has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CELG SEC filings →

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months